Navigation Links
Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 2009
Date:4/15/2009

cer cells, enhancing the effectiveness of current cancer therapies.
  • Neuroscience
    • Abbott is conducting innovative research in neuroscience, where we have developed compounds that target receptors in the brain that help regulate mood, memory and other neurological functions to address conditions such as attention deficit hyperactivity disorder, Alzheimer's disease and schizophrenia.
  • Immunology
    • Abbott's scientific experience with the anti-TNF biologic HUMIRA serves as a strong foundation for our continuing research in immunology. HUMIRA has several indications in Phase III including ulcerative colitis and pediatric Crohn's disease. Also in Phase III is ABT-874, Abbott's anti-IL 12/23 biologic for psoriasis and Crohn's disease. We are also working to advance development of our early discovery programs, including oral DMARD therapies, as well as other potential biologic targets.
    • Additionally, our proprietary DVD-ig technology represents an innovative approach that can target multiple disease-causing antigens with a single biologic agent.
  • Hepatitis C
    • Abbott's antiviral program is focused on the treatment of hepatitis C, a disease that affects more than 180 million people worldwide. Abbott's broad-based hepatitis C program includes our partnership with Enanta Pharmaceuticals to develop protease inhibitors as well as our internal polymerase inhibitor program. Abbott has three HCV compounds in clinical development.
  • Vascular Devices
    • XIENCE PRIME - Abbott's next-generation DES that capitalizes on the proven attributes of XIENCE V while improving deliverability, especially in longer lengths and complex anatomy. We expect to launch XIENCE PRIME in Europe by year-end 2009.'/>"/>

    SOURCE Abbott
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine news :

    1. Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease
    2. Abbott Hosts Conference Call for First-Quarter Earnings
    3. Abbott Launches VOYAGER(TM) NC Coronary Balloon Catheter
    4. Abbott to Present at Cowen Annual Health Care Conference
    5. Abbott Announces Required Offer to Repurchase Convertible Senior Subordinated Notes of Its AMO Subsidiary
    6. Abbott Completes Acquisition of Advanced Medical Optics
    7. Abbott Opens New Pediatric Nutrition Manufacturing Facility in Singapore
    8. Abbott Successfully Completes Tender Offer for Shares of Advanced Medical Optics
    9. Abbott Receives European Commission Clearance on Acquisition of Advanced Medical Optics
    10. Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument
    11. Abbott Acquisition of Advanced Medical Optics Clears U.S. Antitrust Review
  • Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2015)... ... 31, 2015 , ... A family-run business in Grand Rapids, ... sourced all over the world, then manufactured into specific formulations in northern Michigan. ... highest-quality oils in the industry, which we are bringing to consumers at prices ...
    (Date:7/31/2015)... , ... July 31, 2015 , ... Super-Sod wants to ... a Super-Sod Pro Page as the perfect fit for such a goal. ... and articles. The social website is a dynamic site that spreads home and home ...
    (Date:7/31/2015)... ... ... India Network Foundation sponsors visitor health insurance program for all non-US ... past 25 years. As India Network offers coverage for all age groups, many elderly ... their children and grand children. India Network specializes in covering pre-existing conditions when ...
    (Date:7/31/2015)... ... July 31, 2015 , ... With the recent ... of individuals who remain undiagnosed, treatment options for patients are becoming more prevalent ... CPAP therapy due to its overall lack of comfort and highly invasive nature, ...
    (Date:7/30/2015)... ... ... The Venetian on Grace Bay in the Turks & Caicos Islands is pleased to announce ... 40% on their stay while enjoying some of the most beautiful ocean views in the ... a chance to reconnect with loved ones and rediscover one's best self. The sea ...
    Breaking Medicine News(10 mins):Health News:Living Pure Essential Oils takes Therepeutic Essential Oil Market by Storm 2Health News:Super-Sod Created a Landscape Profile on Houzz.com for Home Garden Design 2Health News:India Network Visitor Health Insurance Announces Completion of Food Grains Distribution to Godavari Pushkaram Visitors, Andhra Pradesh, India 2Health News:India Network Visitor Health Insurance Announces Completion of Food Grains Distribution to Godavari Pushkaram Visitors, Andhra Pradesh, India 3Health News:Oravan Sleep Apnea Device Gains Traction in Sleep Industry 2Health News:The Venetian on Grace Bay in Turks & Caicos Islands Offers 40% Savings This Fall. 2
    ... from nagging tinnitus can benefit from internet-based therapy just ... therapy sessions. These are the findings of a German-Swedish ... tried out various forms of therapy over a ten-week ... group therapy sessions was significantly better than that of ...
    ... March 7 (HealthDay News) -- Exposure to cocaine, tobacco ... score lower on academic tests, according to a new ... with no signs of fetal alcohol syndrome, was associated ... and spelling, Boston University researchers found. The negative ...
    ... TUESDAY, March 6 (HealthDay News) -- Most stroke patients undergo ... contributes to the rising costs of stroke care in the ... researchers analyzed data from more than 600,000 patients diagnosed with ... that 95 percent of the patients who had MRI scans ...
    ... 6 (HealthDay News) -- A smoking ban in Scotland ... a new study finds. The nationwide ban on smoking ... analyzed data on preterm delivery and small-for-gestational-age babies born between ... who smoked dropped from more than 25 percent before the ...
    ... When faced with stressful situations, older adults who sleep poorly ... new study finds. The marker, called interleukin-6 (IL-6), has ... cardiovascular disease, diabetes and psychiatric problems. "Our study suggests ... and what poor sleep may be doing to our physiological ...
    ... and has many ways of evading the drugs used by oncologists ... , Now, ... advanced form of melanoma gets around an inhibitor, Zelboraf, which targets ... of the melanoma genome that encodes proteins, called the exome, Jonsson ...
    Cached Medicine News:Health News:Internet-based therapy relieves persistent tinnitus 2Health News:Fetal Cocaine Exposure May Not Affect Kids' Academics: Study 2Health News:Brain Scans Overused on U.S. Stroke Patients, Study Says 2Health News:Poor Sleep May Impact Stress Response in Older Adults 2Health News:UCLA scientists uncover mechanism for melanoma drug resistance 2Health News:UCLA scientists uncover mechanism for melanoma drug resistance 3
    (Date:7/31/2015)... CHICAGO , July 31, 2015 ... Composition Analyzers Market by Product (Bioimpedance Analyzers (BIA), Dual-Energy ... and Hydrostatic Weighing) - Global Analysis & Forecast to ... Market was pegged at $911.1 Million 2014 and is ... at a CAGR of 9.4% from 2014 to 2019. ...
    (Date:7/31/2015)... , July 31, 2015 ... solutions for video, data and cloud computing operators ... a leading pharma giant for Internet of Things ... IoT applications offered on subscription model. ... Pharma giant is striving for business innovations to ...
    (Date:7/30/2015)... 30, 2015 Edwards Lifesciences Corporation (NYSE: EW ... and hemodynamic monitoring, today announced that Robert A. Ingram ... "Bob is an ardent champion for innovation in the ... have him on Edwards, board as we pursue our focused ... and CEO.  "Bob has provided a valuable perspective to our ...
    Breaking Medicine Technology:Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2
    ... WARSAW, Ind., April 12, 2011 Zimmer Holdings, Inc. (NYSE: ... quarter 2011 sales and earnings conference call will be broadcast ... 8:00 a.m. Eastern Time.  A news release detailing the quarterly ... the morning of the conference call. The ...
    ... April 12, 2011 /PRNewswire-Asia-FirstCall/ -- China Botanic Pharmaceutical ... or the "Company"), a developer, manufacturer and distributor ... ("TCM") in China, today announced that its wholly ... has received official approval to produce water-based mixtures. ...
    Cached Medicine Technology:Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2011 Results 2China Botanic Pharmaceutical Approved to Produce Water-Based Mixtures 2China Botanic Pharmaceutical Approved to Produce Water-Based Mixtures 3
    Hypervisor III Central Monitoring System...
    For the critical care environment, telemetry, emergency room and other monitoring areas....
    The CIC Pro Clinical Information Center brings together vital patient information from multiple monitoring devices....
    ... is a solution for hospitals, communicating ... signs monitoring. Waveform and numeric data ... simultaneous display of up to 32 ... trends are stored automatically. Alarms provide ...
    Medicine Products: